$SNTA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in MADRIGAL PHARMACEUTICALS, INC.. Get notifications about new insider transactions in MADRIGAL PHARMACEUTICALS, INC. for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2021SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA119.4950,0005,974,50050,000
Feb 23 2021SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseA119.4932,0003,823,68032,000
Feb 23 2021SNTAMADRIGAL PHARMACEU ...Sukhija RemyChief Commercial Of ...Option ExerciseA119.4924,0002,867,76024,000
Feb 23 2021SNTAMADRIGAL PHARMACEU ...Lynch Brian JosephSVP and General Cou ...Option ExerciseA119.4932,0003,823,68032,000
Feb 23 2021SNTAMADRIGAL PHARMACEU ...Taub RebeccaSee RemarksOption ExerciseA119.4944,0005,257,56044,000
Dec 01 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0043,53702,310,5212.4 M to 2.3 M (-1.85 %)
Dec 01 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0043,53702,310,5212.4 M to 2.3 M (-1.85 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0045,460043,53789 K to 43.5 K (-51.08 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0045,460043,53789 K to 43.5 K (-51.08 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0031,650049,73081.4 K to 49.7 K (-38.89 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0031,650049,73081.4 K to 49.7 K (-38.89 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.001,468,35002,260,7913.7 M to 2.3 M (-39.38 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.001,468,35002,260,7913.7 M to 2.3 M (-39.38 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0045,460043,53789 K to 43.5 K (-51.08 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0045,460043,53789 K to 43.5 K (-51.08 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0031,650049,73081.4 K to 49.7 K (-38.89 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0031,650049,73081.4 K to 49.7 K (-38.89 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.001,468,35002,260,7913.7 M to 2.3 M (-39.38 %)
Sep 04 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.001,468,35002,260,7913.7 M to 2.3 M (-39.38 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellS107.647,303786,09542,87550.2 K to 42.9 K (-14.55 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellS110.0310,1971,121,97650,17860.4 K to 50.2 K (-16.89 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellS110.7312,5001,384,12560,37572.9 K to 60.4 K (-17.15 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS107.647,303786,09542,87550.2 K to 42.9 K (-14.55 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS110.0310,1971,121,97650,17860.4 K to 50.2 K (-16.89 %)
Aug 19 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS110.7312,5001,384,12560,37572.9 K to 60.4 K (-17.15 %)
Aug 10 2020SNTAMADRIGAL PHARMACEU ...Lynch Brian JosephSee RemarksOption ExerciseA103.1020,0002,062,00020,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...Daly James MDirectorOption ExerciseA111.066,000666,3606,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...Gollust Keith RDirectorOption ExerciseA111.066,000666,3606,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA111.066,000666,3606,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseA111.066,000666,3606,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA111.066,000666,3606,000
Jun 18 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorOption ExerciseA111.066,000666,3606,000
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0044,903072,875117.8 K to 72.9 K (-38.13 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.0044,903072,875117.8 K to 72.9 K (-38.13 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.006,772081,38088.2 K to 81.4 K (-7.68 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.006,772081,38088.2 K to 81.4 K (-7.68 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.00360,56103,729,1414.1 M to 3.7 M (-8.82 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellJ0.00360,56103,729,1414.1 M to 3.7 M (-8.82 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0044,903072,875117.8 K to 72.9 K (-38.13 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.0044,903072,875117.8 K to 72.9 K (-38.13 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.006,772081,38088.2 K to 81.4 K (-7.68 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.006,772081,38088.2 K to 81.4 K (-7.68 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.00360,56103,729,1414.1 M to 3.7 M (-8.82 %)
May 29 2020SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellJ0.00360,56103,729,1414.1 M to 3.7 M (-8.82 %)
Mar 05 2020SNTAMADRIGAL PHARMACEU ...Lynch Brian JosephSVP and General Cou ...Option ExerciseA91.7932,0002,937,28032,000
Mar 05 2020SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA91.7950,0004,589,50050,000
Mar 05 2020SNTAMADRIGAL PHARMACEU ...Taub RebeccaPres., R&D, and CMOOption ExerciseA91.7944,0004,038,76044,000
Mar 05 2020SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseA91.7932,0002,937,28032,000
Feb 26 2020SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorSellS131.6010,0001,316,00020,00030 K to 20 K (-33.33 %)
Feb 26 2020SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorSellS112.5420,0002,250,800020 K to 0 (-100.00 %)
Dec 13 2019SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellS105.4725,3202,670,50088,152113.5 K to 88.2 K (-22.31 %)
Dec 13 2019SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLC10% OwnerSellS105.471,174,680123,893,5004,089,7025.3 M to 4.1 M (-22.31 %)
Dec 13 2019SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS105.4725,3202,670,50088,152113.5 K to 88.2 K (-22.31 %)
Dec 13 2019SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS105.471,174,680123,893,5004,089,7025.3 M to 4.1 M (-22.31 %)
Jul 11 2019SNTAMADRIGAL PHARMACEU ...Taub RebeccaPresident of R&DOption ExerciseA101.308,000810,4008,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA100.4510,0001,004,50010,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA100.4510,0001,004,50010,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...Daly James MDirectorOption ExerciseA100.4520,0002,009,00020,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorOption ExerciseA100.4510,0001,004,50010,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...Gollust Keith RDirectorOption ExerciseA100.4510,0001,004,50010,000
Jul 01 2019SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseA100.4510,0001,004,50010,000
Mar 11 2019SNTAMADRIGAL PHARMACEU ...Taub RebeccaChief Medical Offic ...Option ExerciseA127.9638,0004,862,48038,000
Mar 11 2019SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA127.9650,0006,398,00050,000
Mar 11 2019SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseA127.9628,0003,582,88028,000
Nov 23 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP117.884,000471,520161,128157.1 K to 161.1 K (+2.55 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP124.004,000496,000157,128153.1 K to 157.1 K (+2.61 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorBuyP125.00900112,500298,067297.2 K to 298.1 K (+0.30 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorBuyP124.571,000124,570297,167296.2 K to 297.2 K (+0.34 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorBuyP123.1710012,317296,167296.1 K to 296.2 K (+0.03 %)
Sep 19 2018SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseM9.4520,000189,0000
Sep 19 2018SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorBuyM9.4520,000189,00020,0000 to 20 K
Jun 21 2018SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEU ...Gollust Keith RDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA303.7910,0003,037,90010,000
Jun 13 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseM61.602,734168,4141,640
Jun 13 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseM99.755,223520,9941,205
Jun 13 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...SellS287.4610,0992,903,05941,66851.8 K to 41.7 K (-19.51 %)
Jun 13 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...BuyM61.602,734168,41451,76749 K to 51.8 K (+5.58 %)
Jun 13 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...BuyM99.755,223520,99449,03343.8 K to 49 K (+11.92 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorBuyS287.465,9081,698,314113,472107.6 K to 113.5 K (+5.49 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorBuyS287.465,9081,698,314113,472107.6 K to 113.5 K (+5.49 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS287.46274,09278,790,4865,264,3825.5 M to 5.3 M (-4.95 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorSellS287.46274,09278,790,4865,264,3825.5 M to 5.3 M (-4.95 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...Taub RebeccaChief Medical Offic ...BuyS287.4673,52621,135,784655,540582 K to 655.5 K (+12.63 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...Taub RebeccaChief Medical Offic ...BuyS287.4673,52621,135,784655,540582 K to 655.5 K (+12.63 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLCDirectorSellS287.465,9081,698,314113,472119.4 K to 113.5 K (-4.95 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLCDirectorSellS287.465,9081,698,314113,472119.4 K to 113.5 K (-4.95 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLCDirectorSellS287.46274,09278,790,4865,264,3825.5 M to 5.3 M (-4.95 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...BAY CITY CAPITAL LLCDirectorSellS287.46274,09278,790,4865,264,3825.5 M to 5.3 M (-4.95 %)
Mar 05 2018SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseA124.4528,0003,484,60028,000
Mar 05 2018SNTAMADRIGAL PHARMACEU ...Taub RebeccaChief Medical Offic ...Option ExerciseA124.4538,0004,729,10038,000
Mar 05 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA124.4550,0006,222,50050,000
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.2571149,1009.1 K to 9.1 K (+0.08 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.121,79328,9039,0937.3 K to 9.1 K (+24.56 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.111001,6117,3007.2 K to 7.3 K (+1.39 %)
Aug 24 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.081001,6087,2007.1 K to 7.2 K (+1.41 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.141272,0507,1007 K to 7.1 K (+1.82 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.122,94447,4576,9734 K to 7 K (+73.07 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.103896,2634,0293.6 K to 4 K (+10.69 %)
Aug 23 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.99901,4393,6403.6 K to 3.6 K (+2.54 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.095909,4933,5503 K to 3.6 K (+19.93 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.074407,0712,9602.5 K to 3 K (+17.46 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.042103,3682,5202.3 K to 2.5 K (+9.09 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP16.022003,2042,3102.1 K to 2.3 K (+9.48 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.932003,1862,1101.9 K to 2.1 K (+10.47 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.90101591,9101.9 K to 1.9 K (+0.53 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.804006,3201,9001.5 K to 1.9 K (+26.67 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.792003,1581,5001.3 K to 1.5 K (+15.38 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.772003,1541,3001.1 K to 1.3 K (+18.18 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.721001,5721,1001,000 to 1.1 K (+10.00 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.701001,5701,000900 to 1,000 (+11.11 %)
Aug 22 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorBuyP15.6790014,1039000 to 900
Jun 30 2017SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseA16.4610,000164,60010,000
Jun 30 2017SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA16.4610,000164,60010,000
Jun 30 2017SNTAMADRIGAL PHARMACEU ...Gollust Keith RDirectorOption ExerciseA16.4610,000164,60010,000
Jun 30 2017SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorOption ExerciseA16.4610,000164,60010,000
Jun 30 2017SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA16.4610,000164,60010,000
Mar 06 2017SNTAMADRIGAL PHARMACEU ...Taub RebeccaChief Medical Offic ...Option ExerciseA15.8037,300589,34037,300
Mar 06 2017SNTAMADRIGAL PHARMACEU ...Schneebaum Marc RChief Financial Off ...Option ExerciseA15.8027,300431,34027,300
Mar 06 2017SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA15.8049,600783,68049,600
Nov 21 2016SNTAMADRIGAL PHARMACEU ...Levy Richard SDirectorOption ExerciseA7.3620,000147,20020,000
Oct 24 2016SNTAMADRIGAL PHARMACEU ...CRAVES FRED BDirectorOption ExerciseA12.0120,000240,20020,000
Oct 24 2016SNTAMADRIGAL PHARMACEU ...Gollust Keith RDirectorOption ExerciseA12.0120,000240,20020,000
Oct 24 2016SNTAMADRIGAL PHARMACEU ...BATE KENNETHDirectorOption ExerciseA12.0120,000240,20020,000
Oct 24 2016SNTAMADRIGAL PHARMACEU ...MILLIGAN DAVID VDirectorOption ExerciseA12.0120,000240,20020,000
Jul 26 2016SNTASYNTA PHARMACEUTIC ...CRAVES FRED BDirectorGrantA0.00119,3800119,3800 to 119.4 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...CRAVES FRED BDirectorGrantA0.005,538,47405,538,4740 to 5.5 M
Jul 26 2016SNTASYNTA PHARMACEUTIC ...CRAVES FRED BDirectorGrantA0.00296,0670296,0670 to 296.1 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RChief Financial Off ...Option ExerciseA9.4591,876868,22891,876
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RChief Financial Off ...GrantA0.0022,969042,27719.3 K to 42.3 K (+118.96 %)
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA9.45287,1152,713,237287,115
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00729,0660729,0660 to 729.1 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00143,5570143,703146 to 143.7 K (+98,326.71 %)
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.0014601460 to 146
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Taub RebeccaChief Medical Offic ...Option ExerciseA9.45143,5571,356,614143,557
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Taub RebeccaChief Medical Offic ...GrantA0.0028,7400432,872404.1 K to 432.9 K (+7.11 %)
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Taub RebeccaChief Medical Offic ...GrantA0.00404,1320404,1320 to 404.1 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...Taub RebeccaChief Medical Offic ...GrantA0.00729,0660729,0660 to 729.1 K
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Schor ChenFormer President an ...Payment of ExerciseF9.4814,250135,09037,17851.4 K to 37.2 K (-27.71 %)
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Schor ChenFormer President an ...GrantA0.0042,857051,4288.6 K to 51.4 K (+500.02 %)
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RSVP and CFOPayment of ExerciseF9.488,54881,03519,30827.9 K to 19.3 K (-30.69 %)
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RSVP and CFOGrantA0.0025,714027,8562.1 K to 27.9 K (+1,200.47 %)
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Rieder Wendy EFormer SVP, Gen. Co ...Payment of ExerciseF9.488,55081,05417,73026.3 K to 17.7 K (-32.53 %)
Jul 22 2016SNTASYNTA PHARMACEUTIC ...Rieder Wendy EFormer SVP, Gen. Co ...GrantA0.0025,714026,280566 to 26.3 K (+4,543.11 %)
Jan 05 2016SNTASYNTA PHARMACEUTIC ...Morenstein Scott DDirectorGrantA0.0017,857017,8570 to 17.9 K

Page:   1 2 3 4 4 next >